596 related articles for article (PubMed ID: 25443181)
1. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
2. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
Brunner M; Haueter I; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
[TBL] [Abstract][Full Text] [Related]
3. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
4. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
6. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
8. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
11. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
12. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
[TBL] [Abstract][Full Text] [Related]
13. COMBINED VITRECTOMY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOR REFRACTORY MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY, RETINAL VEIN OCCLUSION, AND NONINFECTIOUS POSTERIOR UVEITIS.
Pang JP; Son G; Yoon YH; Kim JG; Lee JY
Retina; 2020 Jan; 40(1):56-65. PubMed ID: 30312262
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
Landré C; Zourdani A; Gastaud P; Baillif S
J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Cheng KC; Wu WC; Chen KJ
Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]